• 1
    Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87:2095147.
  • 2
    Tarlow JK, Blakemore AI, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91:4034.
  • 3
    Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106:63742.
  • 4
    Tountas NA, Casini-Raggi V, Yang H et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999; 117:80613.
  • 5
    Crusius JB, Pena AS, Van Oosten BW et al. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 1995; 346:979.
  • 6
    Blakemore AI, Watson PF, Weetman AP et al. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80:1115.
  • 7
    Blakemore AI, Cox A, Gonzalez AM et al. Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet 1996; 97:36974.DOI: 10.1007/s004390050055
  • 8
    Andus T, Daig R, Vogl D et al. Imbalance of the interleukin 1 system in colonic mucosa — association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2. Gut 1997; 41:6517.
  • 9
    Danis VA, Millington M, Hyland VJ et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99:30310.
  • 10
    Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 1998; 47:1958.DOI: 10.1046/j.1365-3083.1998.00300.x
  • 11
    Hurme M & Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1 β genes. Eur J Immunol 1998; 28:2598602.DOI: 10.1002/(sici)1521-4141(199808)28:08<2598::aid-immu2598>;2-b
  • 12
    Hacker UT, Jelinek T, Erhardt S et al. In vivo synthesis of tumor necrosis factor-α in healthy humans after live yellow fever vaccination. J Infect Dis 1998; 177:7748.
  • 13
    Fang XM, Schroder S, Hoeft A et al. Comparison of two polymorphisms of the interleukin-1 gene family: interleukin-1 receptor antagonist polymorphism contributes to susceptibility to severe sepsis. Crit Care Med 1999; 27:13304.
  • 14
    El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398402.DOI: 10.1038/35006081
  • 15
    Mandrup-Poulsen T, Pociot F, Molvig J et al. Monokine antagonism is reduced in patients with IDDM. Diabetes 1994; 43:12427.